Why Cannabis Concentrates Are a Big Deal for Investors
Ryan Allway
March 26th, 2019
Exclusive, News, Top Story
The term “concentrate” is widely used across the cannabis industry, but the definition is ambiguous since it encompasses any product procured through an extraction process. While hash and shatter have been staples of the cannabis industry for years, new extraction techniques and upcoming legalization could make concentrates even more important.
Cannabis concentrates contain high levels of cannabinoids and they can be incorporated into many different products formats. For example, vaporizers provide recreational users with a healthier alternative to smoking; topicals can help relieve pain or improve skincare; and, new pharmaceuticals could forever change the medical field.
Let’s take a closer look at concentrates, why investors should care, and some companies pioneering the space that they may want to consider.
What Are Concentrates?
Most cannabis concentrates are created using solvents, such as CO2 or ethanol, to strip compounds from the cannabis plant. The result is a solid, paste or liquid that contains a high concentration of cannabinoids, such as tetrahydrocannabinol (THC), cannabidiol (CBD) or other lesser known cannabinoids.
For example, cannabis distillate is commonly created using a complex CO2 extraction process. Since distillate contains no taste, smell, or flavor, it’s commonly used as a base for edibles and vape cartridges. Cannabinoid concentrates can reach upwards of 80 percent in some distillates, making them very potent.
Examples of Cannabis Concentrates
Other cannabis concentrates don’t involve the use of any solvents. For instance, hash is created by compressing the resin — or the powdery substance on a cannabis plant — to create a paste-like product that has been a staple of the cannabis industry and many home enthusiasts for years.
A Rapidly Growing Market
Cannabis flower sales have been falling across North America following the legalization of adult-use cannabis. While smoking cannabis flower is the original consumption method, many consumers are seeking out vaporizers, edibles and other products that involve fewer health risks as they are becoming legal in new markets.
Some U.S. states permit cannabis concentrates but not cannabis flower for these health reasons. For example, Florida’s medical marijuana laws provide consumers with access to cannabis concentrates but don’t allow the smoking of cannabis flower. Non-smokable forms of cannabis also continue to experience greater growth than their smokable counterparts.
At the same time, cannabis concentrates are being used across a wider range of consumer products. Many skincare products have started incorporating cannabidiol (CBD) given its anti-inflammatory properties and other potential benefits. Even pet products are starting to see CBD-infused options that promote possible health benefits.
Pharmaceutical companies are also leveraging cannabis concentrates given their greater potency and greater number of delivery options. Whether over-the-counter or by prescription, cannabinoids have the potential to relieve chronic pain, reduce seizures, and potentially address a wide range of medical conditions.
The global cannabis industry is projected to be worth $146.4 billion by 2025, according to GrandView Research, growing at a robust 34.6 percent compound annual growth rate. But even that size pales in comparison to the multi-trillion dollar wellness and pharmaceutical industries that are ripe for innovation.
The market for concentrates could open wider in October when Health Canada is widely expected to legalize cannabis edibles, beverages and other product formats that make use of cannabis concentrates. If the United States is any indication, these new product formats could reach a much wider audience and drive cannabis revenue sharply higher.
Companies Focused on Concentrates
There are many companies focused on cannabis concentrates, but few are as experienced as Xtraction Services, a provider of equipment distribution and financing for cannabis and hemp manufacturers. Xtraction Services has cultivated a team of engineers that underwrite extraction equipment as well as all post and pre processing equipment to create quality extracts. The company’s core business is to provide purchasing options including leasing, rental, and lay-away for their customers to begin extracting very quickly without a significant cash outlay.
Xtraction Services also offers trained professionals to oversee and manage the entire extraction purchasing process.
PLEASE CLICK HERE to learn more about Xtraction Services
MediPharm Labs (TSX-V: LABS) (OTCQB: MLCPF) is another leading cannabis concentrates producer, in Canada. With an extraction-only business model, the company differentiates itself from many other licensed producers focused on flower. It’s the first LP to receive an active sales and production license for oil without first getting a cultivation license.
The company already has 150,000 kilograms of dried cannabis extraction capacity with expectations to reach 250,000 kilograms of annual capacity by the second quarter. At these levels, management believes that the company could achieve revenue of $550 million to $1 billion with its focus on cannabis oils, distillates, and isolates. MediPharm Labs recently announced its first international sales agreement, signaling its global intentions.
PLEASE CLICK HERE to Download MediPharm Lab’s Investor Presentation
Valens Groworks (CSE: VGW) is another licensed producer in Canada that’s focused on cannabis concentrates. With the first colab facilitating cannabis product development for license producers globally, the company is uniquely focused on becoming a global leader in the space.
The company has one of the largest capacities to extract in Canada with near-term plans to expand its footprint by 25,000 sq. ft. With pending EU GMP Certification, the company’s concentrates will be exportable to anywhere in the world, making it a potential international play on the space.
PLEASE CLICK HERE to Download Valens Groworks Investor Presentation
Looking Ahead
Cannabis concentrates have always been around, but with new extraction processes and creative product development, they’re quickly becoming the hottest subset of the cannabis industry. With Canada poised to legalize concentrates later this year, the industry could see an enormous influx of demand.
Investors interested in the cannabis space may want to focus on companies that have dedicated themselves to cannabis concentrates given these growth rates and the potential for future growth over the coming years.
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Watch CFN Media’s exclusive three part interview with Paul Rosen, one of the most active and diversified investors in the emerging cannabis industry. Paul gives his insights on the global cannabis industry and discusses his new endeavors. Become a CFN Media Client Paul Rosen is a noted career entrepreneur and management consultant. Over the last […]
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
CB Therapeutics, Inc. is a biotechnology company focusing on the innovative production of high value molecules, compounds and rare ingredients from simple feedstock utilizing many different types of hosts and systems, including yeast, bacteria and cell-free expression systems.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
